Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis

Arthritis Research and Therapy

Volumn 11, Issue 2, 2009, Pages

  Chen, Yueh Sheng ^a   Yan, Weixing ^b   Geczy, Carolyn L ^b   Brown, Matthew A ^a   Thomas, Ranjeny ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALGRANULIN A; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; PROTEIN S 100; PROTEIN S 100A12; PROTEIN S 100A9; RHEUMATOID FACTOR; UNCLASSIFIED DRUG; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; AUTOANTIBODY; CALGRANULIN B; IMMUNOGLOBULIN RECEPTOR; S100A12 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; JOINT DESTRUCTION; MAJOR CLINICAL STUDY; MALE; RHEUMATOID ARTHRITIS; RISK FACTOR; VASCULITIS; ARTHROPATHY; BLOOD; BLOOD VESSEL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BLOOD VESSELS; CALGRANULIN A; CALGRANULIN B; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; JOINT DISEASES; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; RISK FACTORS; S100 PROTEINS; YOUNG ADULT;

EID: 64549129099     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2645     Document Type: Article

References (74)

1. Carroll L Hannawi S Marwick T Thomas R Rheumatoid arthritis: Links with cardiovascular disease and the receptor for advanced glycation end products Wien Med Wochenschr 2006, 156:42-52 10.1007/s10354-005-0242-9 16465613
2. van Beijnum JR Buurman WA Griffioen AW Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1) Angiogenesis 2008, 11:91-99 10.1007/s10456-008-9093-5 18264787
3. Sunahori K Yamamura M Yamana J Takasugi K Kawashima M Makino H Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritis Arthritis Rheum 2006, 54:97-104 10.1002/art.21524 16385501
4. Mohamed AK Bierhaus A Schiekofer S Tritschler H Ziegler R Nawroth PP The role of oxidative stress and NF-kappaB activation in late diabetic complications Biofactors 1999, 10:157-167 10.1002/biof.5520100211 10609877
5. Bucciarelli LG Wendt T Rong L Lalla E Hofmann MA Goova MT Taguchi A Yan SF Yan SD Stern DM Schmidt AM RAGE is a multiligand receptor of the immunoglobulin superfamily: Implications for homeostasis and chronic disease Cell Mol Life Sci 2002, 59:1117-1128 10.1007/s00018-002-8491-x 12222959
6. Taniguchi N Kawahara K Yone K Hashiguchi T Yamakuchi M Goto M Inoue K Yamada S Ijiri K Matsunaga S Nakajima T Komiya S Maruyama I High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine Arthritis Rheum 2003, 48:971-981 10.1002/art.10859 12687539
7. Batliwalla FM Baechler EC Xiao X Li W Balasubramanian S Khalili H Damle A Ortmann WA Perrone A Kantor AB Gulko PS Kern M Furie R Behrens TW Gregersen PK Peripheral blood gene expression profiling in rheumatoid arthritis Genes Immun 2005, 6:388-397 10.1038/sj.gene.6364209 15973463
8. Liao H Wu J Kuhn E Chin W Chang B Jones MD O'Neil S Clauser KR Karl J Hasler F Roubenoff R Zolg W Guild BC Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis Arthritis Rheum 2004, 50:3792-3803 10.1002/art.20720 15593230
9. Edwards CJ Feldman JL Beech J Shields KM Stover JA Trepicchio WL Larsen G Foxwell BM Brennan FM Feldmann M Pittman DD Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis Mol Med 2007, 13:40-58 1869619 17515956 10.2119/ 2006-00056.Edwards
10. Foell D Kane D Bresnihan B Vogl T Nacken W Sorg C Fitzgerald O Roth J Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis Rheumatology (Oxford) 2003, 42:1383-1389 10.1093/rheumatology/keg385 12832707
11. Sunahori K Yamamura M Yamana J Takasugi K Kawashima M Yamamoto H Chazin WJ Nakatani Y Yui S Makino H The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis Arthritis Res Ther 2006, 8:R69 1526633 16613612 10.1186/ar1939
12. Yonekura H Yamamoto Y Sakurai S Petrova RG Abedin MJ Li H Yasui K Takeuchi M Makita Z Takasawa S Okamoto H Watanabe T Yamamoto H Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury Biochem J 2003 370 1097, 1109:1223244-12495433 10.1042/BJ20021371
13. Pullerits R Brisslert M Jonsson IM Tarkowski A Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1 Arthritis Rheum 2006, 54:3898-3907 10.1002/art.22217 17133598
14. Liliensiek B Weigand MA Bierhaus A Nicklas W Kasper M Hofer S Plachky J Grone HJ Kurschus FC Schmidt AM Yan SD Martin E Schleicher E Stern DM Hammerling GG Nawroth PP Arnold B Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response J Clin Invest 2004, 113:1641-1650 419481 15173891
15. Hofmann MA Drury S Hudson BI Gleason MR Qu W Lu Y Lalla E Chitnis S Monteiro J Stickland MH Bucciarelli LG Moser B Moxley G Itescu S Grant PJ Gregersen PK Stern DM Schmidt AM RAGE and arthritis: The G82S polymorphism amplifies the inflammatory response Genes Immun 2002, 3:123-135 10.1038/sj.gene.6363861 12070776
16. Geroldi D Falcone C Emanuele E D'Angelo A Calcagnino M Buzzi MP Scioli GA Fogari R Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension J Hypertens 2005, 23:1725-1729 10.1097/01.hjh.0000177535.45785.64 16093918
17. Pullerits R Bokarewa M Dahlberg L Tarkowski A Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control Arthritis Res Ther 2005, 7:R817-824 1175032 15987483 10.1186/ar1749
18. Koyama H Shoji T Yokoyama H Motoyama K Mori K Fukumoto S Emoto M Shoji T Tamei H Matsuki H Sakurai S Yamamoto Y Yonekura H Watanabe T Yamamoto H Nishizawa Y Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis Arterioscler Thromb Vasc Biol 2005, 25:2587-2593 10.1161/01.ATV.0000190660.32863.cd 16224056
19. Carroll L Frazer IH Turner M Marwick TH Thomas R Receptor for advanced glycation end products glycine 82 serine polymorphism and risk of cardiovascular events in rheumatoid arthritis Arthritis Res Ther 2007, 9:R39 1906817 17425804 10.1186/ar2175
20. Ravasi T Hsu K Goyette J Schroder K Yang Z Rahimi F Miranda LP Alewood PF Hume DA Geczy C Probing the S100 protein family through genomic and functional analysis Genomics 2004, 84:10-22 10.1016/j.ygeno.2004.02.002 15203200
21. Foell D Frosch M Sorg C Roth J Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation Clin Chim Acta 2004, 344:37-51 10.1016/j.cccn.2004.02.023 15149869
22. Renaud W Merten M Figarella C Increased coexpression of CFTR and S100 calcium binding proteins MRP8 and MRP14 mRNAs in cystic fibrosis human tracheal gland cells Biochem Biophys Res Commun 1994, 201:1518-1525 10.1006/bbrc.1994.1876 7517672
23. Zwadlo G Bruggen J Gerhards G Schlegel R Sorg C Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues Clin Exp Immunol 1988, 72:510-515 1541584 3048809
24. Yui S Nakatani Y Mikami M Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity Biol Pharm Bull 2003, 26:753-760 10.1248/bpb.26.753 12808281
25. Yang Z Tao T Raftery MJ Youssef P Di Girolamo N Geczy CL Proinflammatory properties of the human S100 protein S100A12 J Leukoc Biol 2001, 69:986-994 11404386
26. Hammer HB Odegard S Fagerhol MK Landewe R Heijde van der D Uhlig T Mowinckel P Kvien TK Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis Ann Rheum Dis 2007, 66:1093-1097 10.1136/ ard.2006.064741 17234650
27. Madland TM Hordvik M Haga HJ Jonsson R Brun JG Leukocyte protein calprotectin and outcome in rheumatoid arthritis. A longitudinal study Scand J Rheumatol 2002, 31:351-354 10.1080/030097402320817077 12492250
28. Brun JG Haga HJ Boe E Kallay I Lekven C Berntzen HB Fagerhol MK Calprotectin in patients with rheumatoid arthritis: Relation to clinical and laboratory variables of disease activity J Rheumatol 1992, 19:859-862 1404121
29. Yang Z Yan WX Cai H Tedla N Armishaw C Di Girolamo N Wang HW Hampartzoumian T Simpson JL Gibson PG Hunt J Hart P Hughes JM Perry MA Alewood PF Geczy CL S100A12 provokes mast cell activation: A potential amplification pathway in asthma and innate immunity J Allergy Clin Immunol 2007, 119:106-114 10.1016/j.jaci.2006.08.021 17208591
30. Mori Y Kosaki A Kishimoto N Kimura T Iida K Fukui M Nakajima F Nagahara M Urakami M Iwasaka T Matsubara H Increased plasma S100A12 (EN-RAGE) levels in hemodialysis patients with atherosclerosis Am J Nephrol 2008, 29:18-24 10.1159/000148646 18663285
31. Hofmann MA Drury S Fu C Qu W Taguchi A Lu Y Avila C Kambham N Bierhaus A Nawroth P Neurath MF Slattery T Beach D McClary J Nagashima M Morser J Stern D Schmidt AM RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides Cell 1999, 97:889-901 10.1016/S0092-8674(00)80801-6 10399917
32. Valencia JV Mone M Koehne C Rediske J Hughes TE Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: Lack of activity of endotoxin-free albumin-derived advanced glycation end products Diabetologia 2004, 47:844-852 10.1007/s00125-004-1392-9 15127201
33. Ryckman C Vandal K Rouleau P Talbot M Tessier PA Proinflammatory activities of S100: Proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion J Immunol 2003, 170:3233-3242 12626582
34. Okutomi T Tanaka T Yui S Mikami M Yamazaki M Abe S Yamaguchi H Anti-Candida activity of calprotectin in combination with neutrophils or lactoferrin Microbiol Immunol 1998, 42:789-793 9886152
35. Kerkhoff C Eue I Sorg C The regulatory role of MRP8 (S100A8) and MRP14 (S100A9) in the transendothelial migration of human leukocytes Pathobiology 1999, 67:230-232 10.1159/000028098 10725790
36. Ehlermann P Eggers K Bierhaus A Most P Weichenhan D Greten J Nawroth PP Katus HA Remppis A Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products Cardiovasc Diabetol 2006, 5:6 1475836 16573830 10.1186/1475-2840-5-6
37. Harrison CA Raftery MJ Walsh J Alewood P Iismaa SE Thliveris S Geczy CL Oxidation regulates the inflammatory properties of the murine S100 protein S100A8 J Biol Chem 1999, 274:8561-8569 10.1074/jbc.274.13.8561 10085090
38. Lim SY Raftery M Cai H Hsu K Yan WX Hseih HL Watts RN Richardson D Thomas S Perry M Geczy CL S-nitrosylated S100A8: Novel anti-inflammatory properties J Immunol 2008, 181:5627-5636 18832721
39. McCormick MM Rahimi F Bobryshev YV Gaus K Zreiqat H Cai H Lord RS Geczy CL S100A8 and S100A9 in human arterial wall. Implications for atherogenesis J Biol Chem 2005, 280:41521-41529 10.1074/jbc.M509442200 16216873
40. Harja E Bu DX Hudson BI Chang JS Shen X Hallam K Kalea AZ Lu Y Rosario RH Oruganti S Nikolla Z Belov D Lalla E Ramasamy R Yan SF Schmidt AM Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice J Clin Invest 2008, 118:183-194 2129235 18079965 10.1172/JCI32703
41. Falcone C Emanuele E D'Angelo A Buzzi MP Belvito C Cuccia M Geroldi D Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men Arterioscler Thromb Vasc Biol 2005, 25:1032-1037 10.1161/01.ATV.0000160342.20342.00 15731496
42. Arnett FC Edworthy SM Bloch DA McShane DJ Fries JF Cooper NS Healey LA Kaplan SR Liang MH Luthra HS Medsger TA Jr Mitchell DM Neustadt DH Pinals RS Schaller JG Sharp JT Wilder RL Hunder GG The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 1988, 31:315-324 10.1002/ art.1780310302 3358796
43. Alpert JS Thygesen K Antman E Bassand JP Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/ American College of Cardiology Committee for the redefinition of myocardial infarction J Am Coll Cardiol 2000, 36:959-969 10.1016/ S0735-1097(00)00804-4 10987628
44. Wilson PW D'Agostino RB Levy D Belanger AM Silbershatz H Kannel WB Prediction of coronary heart disease using risk factor categories Circulation 1998, 97:1837-1847 9603539
45. Grundy SM Cleeman JI Daniels SR Donato KA Eckel RH Franklin BA Gordon DJ Krauss RM Savage PJ Smith SC Jr Spertus JA Costa F Diagnosis and management of the metabolic syndrome. An American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Executive summary Cardiol Rev 2005, 13:322-327 16708441
46. Cockcroft DW Gault MH Prediction of creatinine clearance from serum creatinine Nephron 1976, 16:31-41 10.1159/000180580 1244564
47. Heijde van der D How to read radiographs according to the Sharp/van der Heijde method J Rheumatol 2000, 27:261-263 10648051
48. Bottini N Musumeci L Alonso A Rahmouni S Nika K Rostamkhani M MacMurray J Meloni GF Lucarelli P Pellecchia M Eisenbarth GS Comings D Mustelin T A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes Nat Genet 2004, 36:337-338 10.1038/ng1323 15004560
49. Gregersen PK Silver J Winchester RJ The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis Arthritis Rheum 1987, 30:1205-1213 10.1002/ art.1780301102 2446635
50. Gregersen PK Silver J Winchester RJ The shared epitope hypothesis: An approach to understanding the molecular genetics of suseptibility to rheumatoid arthritis Arthritis Rheum 1987, 30:1205-1213 10.1002/ art.1780301102 2446635
51. Nakamura K Yamagishi SI Adachi H Kurita-Nakamura Y Matsui T Yoshida T Sato A Imaizumi T Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease Diabetes Metab Res Rev 2007, 23:368-371 10.1002/dmrr.690 17024691
52. Ansell BJ Navab M Hama S Kamranpour N Fonarow G Hough G Rahmani S Mottahedeh R Dave R Reddy ST Fogelman AM Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment Circulation 2003, 108:2751-2756 10.1161/01.CIR.0000103624.14436.4B 14638544
53. Van Lenten BJ Hama SY de Beer FC Stafforini DM McIntyre TM Prescott SM La Du BN Fogelman AM Navab M Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures J Clin Invest 1995, 96:2758-2767 185985 8675645 10.1172/JCI118345
54. Navab M Berliner JA Subbanagounder G Hama S Lusis AJ Castellani LW Reddy S Shih D Shi W Watson AD Van Lenten BJ Vora D Fogelman AM HDL and the inflammatory response induced by LDL-derived oxidized phospholipids Arterioscler Thromb Vasc Biol 2001, 21:481-488 11304461
55. McMahon M Grossman J FitzGerald J Dahlin-Lee E Wallace DJ Thong BY Badsha H Kalunian K Charles C Navab M Fogelman AM Hahn BH Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis Arthritis Rheum 2006, 54:2541-2549 10.1002/ art.21976 16868975
56. Eue I Pietz B Storck J Klempt M Sorg C Transendothelial migration of 27E10+ human monocytes Int Immunol 2000, 12:1593-1604 10.1093/intimm/ 12.11.1593 11058579
57. Sviridov D Mukhamedova N Remaly AT Chin-Dusting J Nestel P Antiatherogenic functionality of high density lipoprotein: How much versus how good J Atheroscler Thromb 2008, 15:52-62 18385533
58. de Seny D Fillet M Ribbens C Maree R Meuwis MA Lutteri L Chapelle JP Wehenkel L Louis E Merville MP Malaise M Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis Clin Chem 2008, 54:1066-1075 10.1373/ clinchem.2007.099549 18436720
59. Bovin LF Rieneck K Workman C Nielsen H Sorensen SF Skjodt H Florescu A Brunak S Bendtzen K Blood cell gene expression profiling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor Immunol Lett 2004, 93:217-226 10.1016/j.imlet.2004.03.018 15158620
60. Vencovsky J Machacek S Sedova L Kafkova J Gatterova J Pesakova V Ruzickova S Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis Ann Rheum Dis 2003, 62:427-430 1754544 12695154 10.1136/ard.62.5.427
61. Youssef P Roth J Frosch M Costello P Fitzgerald O Sorg C Bresnihan B Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane J Rheumatol 1999, 26:2523-2528 10606357
62. Hsu K Passey RJ Endoh Y Rahimi F Youssef P Yen T Geczy CL Regulation of S100A8 by glucocorticoids J Immunol 2005, 174:2318-2326 15699168
63. Cheng P Corzo CA Luetteke N Yu B Nagaraj S Bui MM Ortiz M Nacken W Sorg C Vogl T Roth J Gabrilovich DI Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein J Exp Med 2008, 205:2235-2249 2556797 18809714 10.1084/jem.20080132
64. Vogl T Tenbrock K Ludwig S Leukert N Ehrhardt C van Zoelen MA Nacken W Foell D Poll van der T Sorg C Roth J Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock Nat Med 2007, 13:1042-1049 10.1038/nm1638 17767165
65. Wittkowski H Hirono K Ichida F Vogl T Ye F Yanlin X Saito K Uese K Miyawaki T Viemann D Roth J Foell D Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12 Arthritis Rheum 2007, 56:4174-4181 10.1002/art.23042 18050248
66. Basta G Sironi AM Lazzerini G Del Turco S Buzzigoli E Casolaro A Natali A Ferrannini E Gastaldelli A Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein J Clin Endocrinol Metab 2006, 91:4628-4634 10.1210/ jc.2005-2559 16926247
67. Kosaki A Hasegawa T Kimura T Iida K Hitomi J Matsubara H Mori Y Okigaki M Toyoda N Masaki H Inoue-Shibata M Nishikawa M Iwasaka T Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes J Clin Endocrinol Metab 2004, 89:5423-5428 10.1210/jc.2003-032223 15531492
68. Bouma G Lam-Tse WK Wierenga-Wolf AF Drexhage HA Versnel MA Increased serum levels of MRP-8/14 in type 1 diabetes induce an increased expression of CD11b and an enhanced adhesion of circulating monocytes to fibronectin Diabetes 2004, 53:1979-1986 10.2337/diabetes.53.8.1979 15277376
69. Gerli R Goodson NJ Cardiovascular involvement in rheumatoid arthritis Lupus 2005, 14:679-682 10.1191/0961203305lu2199oa 16218466
70. Solomon DH Curhan GC Rimm EB Cannuscio CC Karlson EW Cardiovascular risk factors in women with and without rheumatoid arthritis Arthritis Rheum 2004, 50:3444-3449 10.1002/art.20636 15529391
71. Ridker PM High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease Circulation 2001, 103:1813-1818 11282915
72. Koyama H Yamamoto H Nishizawa Y RAGE and soluble RAGE: Potential therapeutic targets for cardiovascular diseases Mol Med 2007, 13:625-635 2017106 17932553 10.2119/2007-00087.Koyama
73. Altwegg LA Neidhart M Hersberger M Muller S Eberli FR Corti R Roffi M Sutsch G Gay S von Eckardstein A Wischnewsky MB Luscher TF Maier W Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: A novel, early, and sensitive marker of acute coronary syndromes Eur Heart J 2007, 28:941-948 10.1093/eurheartj/ehm078 17387139
74. Mori Y Kosaki A Kishimoto N Kimura T Iida K Fukui M Nakajima F Nagahara M Urakami M Iwasaka T Matsubara H Increased plasma S100A12 (EN-RAGE) levels in hemodialysis patients with atherosclerosis Am J Nephrol 2009, 29:18-24 10.1159/000148646 18663285